Close

G6PC2

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This gene encodes an enzyme belonging to the glucose 6 phosphatase catalytic subunit family. These enzymes are part of a multicomponent integral membrane system that catalyzes the hydrolysis of glucose 6 phosphate, the terminal step in gluconeogenic and glycogenolytic pathways, allowing the release of glucose into the bloodstream. The family member encoded by this gene is found in pancreatic islets and does not exhibit phosphohydrolase activity, but it is a major target of cell mediated autoimmunity in diabetes. Several alternatively spliced transcript variants of this gene have been described, but their biological validity has not been determined.
  • TCR Vector Products

  • TCR Cell Products

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-ZP601 Human anti-G6PC2 T cell receptor (TE4), pCDTCR1 Human TE4 Human FLWSVFMLI HLA-A*0201 Lentiviral vector   Add to Cart   Datasheet
TCR-ZP602 Human anti-G6PC2 T cell receptor (UB6), pCDTCR1 Human UB6 Human RLLCALTSL HLA-A*0201 Lentiviral vector   Add to Cart   Datasheet
TCR-ZP603 Human anti-G6PC2 T cell receptor (VG4), pCDTCR1 Human VG4 Human VLFGLGFAI HLA-A*0201 Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.